NASDAQ:VRTX
Vertex Pharmaceuticals Incorporated
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.vrtx.comipo date
Jul 24, 1991
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients ...Show More
Earnings
Earnings Release in 3 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus